α-Fodrin autoantibodies in the differential diagnosis of MS and Sjögren syndrome
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
It is often difficult to diagnose Sjögren syndrome (SS) with neurologic manifestations as frequently only the nervous system is affected and anti-Ro (SSA) and anti-La (SSB) antibodies are found in fewer than 50% of cases.1,2⇓ In a recent study, we demonstrated that primary progressive multiple sclerosis (PPMS) should be the principal differential diagnosis for SS with CNS manifestations.2 However, the question remains as to whether SS is secondary to MS or whether the two are separate entities.3,4⇓ It was recently reported that antibodies against α-fodrin are both a sensitive and a specific marker for SS.5,6⇓ α-Fodrin is a cytoskeletal protein that binds to the cytoplasmic domains of a variety of molecules expressed on the cell surface. It is abundantly expressed in salivary glands but also other tissues including synapses and is probably involved in exocytosis. α-Fodrin is cleaved by caspase 3 upon apoptosis into …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Babak Hooshmand and Dr. David Smith
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Autoimmune chorea in adultsOrna O’Toole, Vanda A. Lennon, J. Eric Ahlskog et al.Neurology, February 20, 2013 -
Article
Myositis-specific autoantibodies are specific for myositis compared to genetic muscle diseaseAndrew L. Mammen, Livia Casciola-Rosen, Lisa Christopher-Stine et al.Neurology - Neuroimmunology Neuroinflammation, November 19, 2015 -
Articles
Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsyJ. Peltola, P. Kulmala, J. Isojärvi et al.Neurology, July 12, 2000 -
Article
Neurologic autoimmunity and immune checkpoint inhibitorsAutoantibody profiles and outcomesElia Sechi, Svetomir N. Markovic, Andrew McKeon et al.Neurology, August 13, 2020